Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.
Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA ...
Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...
Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...
Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for cancer patients. Enoby targets bone loss in patients on hormone-based ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Cancer specialists have long known that anemia, caused by a lack of healthy red blood cells, can arise when cancer metastasizes to the bone, but it’s been unclear why. A research team led by Princeton ...
Cassandra and Katelyn Harding suffered the loss of their mother before both being diagnosed with rare osteosarcoma GoFundMe Teen sisters were diagnosed with a rare bone cancer after their mother died ...
A 55-year-old man’s swollen toes and fingers turned out to have a much stranger explanation than expected. In a recent case report, the man’s doctors detailed how some of his bones were “completely ...
There are many possible causes of bone pain, including bone cancer. Other causes include arthritis, fracture, and infection. The most significant cause of bone pain is bone cancer. This disease is ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback